< Back to latest news & events

News

Oral Proceedings by videoconference (VICO) in oppositions proceedings to become permanent

November 2022

The pilot project for oral proceedings in opposition proceedings by video conference (VICO) started during the pandemic and has received positive feedback.[1]

The President of the EPO has therefore declared (Decision of 22 November 2022) that, as of 1 January 2023, VICOs will become the default format for oral proceedings in opposition. Only in exceptional circumstances when the opposition division permits it, will oral proceedings in opposition be conducted in person.

The president believes that VICO has enabled parties to save on time and money whilst reducing carbon emissions from travelling in person.

Accordingly oral proceedings will only be held in person if requested by a party or at the instigation of the Opposition Division if there are serious reasons against holding the proceedings by video conference. If a party’s request is refused the refusal is not separately appealable.

Given the experience during the pandemic, and as set out in the Pilot Project Final Report [1], the taking of evidence, including hearing witnesses and inspection, has been successfully conducted by VICO and so is not likely to amount to serious reasons for conducting oral proceedings in person. An exception may be where inspection cannot be adequately conducted using video equipment.

Please see here for the official notice from the EPO.

The decision of the President does not affect Oral Proceedings at the Boards of Appeal. Indeed, in the Enlarged Board of Appeal Decision G1/21 the Enlarged Board clearly stated that whilst oral proceedings by VICO were compatible with the right to be heard enshrined in the EPC they were suboptimal compared with in-person hearings and, as such, in-person hearings should, in the absence of a pandemic, be the default option (Reason 45).

Accordingly we do not expect the President’s Decision to have a knock-on effect at the Board of Appeal.

For further information please contact Dr Chris Moore, Head of Oppositions & Appeals.

[1] Pilot Project Final Report November 2022 (here) – over 77% of respondents found oral proceedings to be “good” or “very good”

Latest updates

Agritech Thymes: The Bite of Implied Consent: Lessons from the Pink Lady Case

Can the supply of a plant variety without clear and defined restrictions on its use be an implicit consent to commercialise it? This case centres on the evidence required to …

Read article

IAM Global Leaders 2026

HGF is proud to announce that we have 3 partners listed as an IAM Global Leader 2026. To qualify for inclusion in the IAM Global Leaders, individuals must be ranked …

Read article

The Bite of Implied Consent: Lessons from the Pink Lady Case

A recent European Union court decision considers the issue of implied consent to commercialise a plant variety, and whether the evidence meets the threshold of “serious doubts” of the validity …

Read article
Event - 5th November 2025

HGF are Gold Sponsors of IAM Live: Navigating the UPC 2025

We’re excited to share that HGF is a Gold Sponsor of IAM Live: Navigating the UPC 2025, taking place on the 5th November at the Marriott Opera Ambassador Hotel in …

Event details

HGF ranked band 1 in Chambers and Partners UK 2026

The Chambers and Partners UK 2026 Guide is now live and HGF has one again been highly ranked as a firm, with several recognised individuals across multiple regions. HGF is …

Read article

How France's investment in digital health, AI, and bioinformatics is transforming the intellectual property (IP) landscape

In recent years, France has become a key player in digital health innovation, driven by strategic government investments under the France 2030 initiative and the French Tech 2030 program. These …

Read article
Event - 14th October 2025

The Future of Protein Production Amsterdam 2025

HGF are proud to be sponsoring the Future of Protein Production Amsterdam 2025, the leading global event bringing together innovators across fermentation, cultivated and plant-based proteins. Date: 29-30th October 2025  …

Event details

A Turning Point for AI Patent Eligibility?

Director Squires Vacates PTAB § 101 Rejection in DeepMind Case In a notable early move as Under Secretary of Commerce and USPTO Director, John Squires has vacated a Patent Trial …

Read article